Generics Makers Challenge AstraZeneca In Crestor MDL
Teva Pharmaceuticals USA Inc., Apotex Corp. and a clutch of other generic-drug makers accused of infringing AstraZeneca PLC's patent for the cholesterol drug Crestor are claiming the company's marketing unit lacks...To view the full article, register now.
Already a subscriber? Click here to view full article